Lynx, a healthcare payments fintech based in Boston, US, has raised $27 million in a Series A funding round led by Flare Capital Partners.Healthcare payments fintech Lynx raises $27m Series AThe round also featured participation from CVS Health Ventures and McKesson Ventures, as well as existing investors .406 Ventures, Obvious Ventures and Frist Cressey Ventures.Victor Lanio, a partner at Flare Capital Partners, will also now join Lynx’s board.The raise builds on the $15 million in Series A funding previously secured by Lynx in 2022 as well as its preceding $2.5 million seed round, bringing the platform’s total funding to date to over $44 million.Co-founded by CEO Matt Renfro and CIO Ken Abel, Lynx operates an API-based platform that enables companies to build and launch healthcare-focused propositions, including Consumer-Directed Health (CDH) accounts, SKU-restricted payment cards for Medicare Advantage, and custom OTC storefronts. Lynx has earmarked the latest cash injection to scale its operations, with a focus on further developing “tailored, API-driven products to streamline the consumer experience and operations for benefits administrators and health plans”.